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Three lanostane-type triterpenoids [lanosta-7,9(11),24-trien-3-one 15,26-dihydroxy, lanosta-7,9(11),24-
trien-26-oic,3-hydroxy and ganoderic acid y], four steroids[ (22E,24R)-ergosta-7,22-dien-3β,5α.6β-triol, 
5α,8α-epidiory (22E,24R-ergosta-6,22-dien-3β-ol, ergosta-5,7,22-trien-3β-ol,7 (ergosterol) and ergosta-
7,22-dien-3β-ol,6] and a benzene derivative (dimethyl phthalate) were isolated from ethyl acetate crude 
extract of Ganoderma zonatum Murill. of oil palm from Cameroon. Their structures were elucidated by 
nuclear magnetic resonance (NMR), electron impact ionization mass spectrum experiments (EI-MS) and 
by comparing with the data reported in literature. The highly oxygenated lanostane  triterpenoid - 
ganoderic acid y-  showed moderate cytotoxicity against two human tumour cell lines, SMMC-7721 
(liver cancer) and A549 (lung cancer) with IC50 values of 33.5 and 29.9 µM, respectively and no activity 
on HL-60, MCF-7 and SW480, while lanosta-7,9(11),24-trien-3-one,15;26-dihydroxy and lanosta-
7,9(11),24-trien-26-oic,3-hydroxy, showed no activity. The three lanostane triterpeniods had the same 
molecular formula, molecular weight, behaviour on the TLC plates, with the same retention factor value 
of 3 (when petroleum ether-acetone was used in the ratio of 3:1), but with slightly different structures. 
These compounds have not been reported occurring together from any other species of Ganoderma. 
Their simultaneous occurrence might thus, serve as a diagnostic chemotaxonomic character for G. 
zonatum, The 
1
H NMR data is provided for the first time for lanosta-7,9(11),24-trien-26-oic,3-hydroxy. 
 





Ganoderma species belong to the division Basidiomycota, 
class Homobasidiomycetes, order Aphyllophorales and 
family Polyporaceae (Alexopoulos et al., 1996; Wasser 
and Weis, 1999a). Ganoderma species are not listed 
among the group of edible mushrooms because the 
fruiting bodies are always thick, corky and tough and do 
not have the fleshy texture characteristics of true edible 
fungi (Jong and Birmingham, 1991). Although species of 
Ganoderma cannot be eaten directly, they have attracted 
great attention all over the world because of their wide 
range of pharmacological values (Yoon et al., 1994; 
Wasser and Weis, 1999b). The bioactive compounds 
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immune-regulatory and hypoglycemic activities. They 
have been known for their antihydrogenic, antitumor, 
antihepatotoxic, antinocieptic, immunodulatory, cardio-
vascular, antibacterial and antiviral values (Chang and 
Buswell, 1996; Chang and Mshigeni, 2001). 
Basidiomycetes, also called macromycetes, are among 
the many diverse organisms and are a major source of 
biologically active natural products (Liu, 2004). They 
provide a rich variety of active secondary metabolites 
(Turner, 1971). The number of different mushroom 
species on earth is estimated at 140000, of which only 
about 10% are known and from those, approximately 700 
species are known to possess significant pharma-
cological properties (Lull et al., 2005; Chang, 1996). 
Medicinal basidiomycetes represent an unlimited source 
of phytochemicals such as primary and secondary 
metabolites (Roja and Rao, 1998). Quite a wide range of 





different classes of chemical compounds have been 
described and their biological properties evaluated 
(Lorenzen and Anke, 1998; Mizuno, 1999). 
Over the past three decades, scientists all over the 
world have isolated more than 150 triterpenes and 50 
pharmacologically active polysaccharides from different 
species of Ganoderma (Kim and Kim, 2002; Lin and 
Chou, 1984; Jong and Birmingham, 1992). Some of 
those bioactive compounds obtained from different basi-
diomycetes are a variety of terpenes, sesquiterpenes, 
steroids and polysaccharides (alone or forming com-
plexes with proteins, like PSK), among others (Lindequist 
et al., 2005). Most of their main pharmacological 
properties like their antitumoral activity have been 
attributed to their ability to modulate the immune system. 
Most of them are immunostimulants, but others are 
immunosuppressive. 
Basidiomycetes mushrooms have been used in folk 
medicine throughout the world since ancient times 
(Arisawa et al., 1986; Wasser, 1999; Stamets, 2000). 
Medicinal mush-rooms useful against cancer are known 
in China, Russia, Japan, Korea, as well as the USA and 
Canada, but less known in most African countries. 
Members of the genus Ganoderma have also been used 
in traditional medicine for centuries in, Japan and Korea.  
In 1997, the worldwide production of Ganoderma was 
approximately 4,300 tons, of which China contributed 
3,000 tons (Chiu et al., 2000). Traditionally in China, 
Ganoderma is highly regarded as a herbal treatment and 
is claimed to alleviate or cure virtually all diseases.   
The medicinal value of the mushrooms is largely a 
function of their secondary metabolites (Hajjaj et al., 
2005). A large number of mushroom-derived compounds, 
both cellular components and secondary metabolites, 
have been shown to affect the immune system and could 
be used to treat a variety of disease states. Compounds 
that appear to enhance or potentiate host resistance are 
being sought for the treatment of cancer, immuno-
deficiency diseases or generalized immune suppression 
after drug treatment (Hajjaj et al., 2005). More than 140 
highly oxygenated lanostane-type triterpenoids have 
been isolated from the fruiting bodies, mycelia and 
spores of Ganoderma lucidium, some of them exhibiting 
a very broad spectrum of biological activities and 
pharmacological functions. Some of them have been 
shown to inhibit histamine release from rats mast cells 
(Komoda et al., 1989), angiotensin-converting enzyme 
and hypocholesterol activities (Hajjaj et al., 2005).  
Ganoderic acids and other triterpenoids have received 
considerable attention due to their conspicuous 
pharmacological activities. Despite the valuable dietary 
and therapeutic benefits of G. lucidum and related 
species, phytochemical evaluation of the active compo-
nents have been performed predominantly in China, 
Korea, Japan and the United states (Paterson, 2006). 
Herbalists usually consider Ganoderma as natural 
regulator,   suppressing    the    immune   system   if  it  is 




overactive and boosting it if it is underactive such that 
traditional healers among the Yoruba people of south-
western Nigeria have used species of Ganoderma in the 
treatment of skin disorder, high blood pressure and 
intestinal disorder (Gao and Yang, 1991). They usually 
regard G. lucidum as immune booster especially when 
combined with other medicinal ingredients. 
In Cameroon and other countries such as Malaysia and 
Indonesia, species of Ganoderma are highly prevalent in 
oil palm plantations, where they are considered patho-
genic (Turner, 1981; Utomo et al., 2005) and several 
control measures have been considered which are aimed 
at killing or reducing the basidiocarp development. 
Ethnomycological studies in Cameroon revealed that a 
species of Ganoderma identified as G. lucidium 
(W.Curt.Fr.) P. Karst is used in the treatment of skin 
infections, boils, abscesses, tumours and also as a 
component in other medicinal preparations (Yongabi et 
al., 2004). There is however, paucity of information on the 
chemical constituents of species of Ganoderma and other 
macro-fungi in general in Cameroon as is the case with 
other Sub-Sahara African countries. The aim of this study 
was to identify the chemical constituents of the Came-
roonian oil palm isolate of Ganoderma zonatum and 
subsequently, to screen some of the pure compounds 
against cancer cell lines in vitro as a rationale for the 
conservation of this medicinal fungus.  
 
 
MATERIALS AND METHODS 
 
General experimental procedures 
 
Optical rotations were measured on a Horiba SEPA-300 polarimeter. 
UV spectra were measured in Shimadzu UV-2401 PC 
spectrophotometer. IR spectra were obtained on a Tensor 27 with 
KBr pellets. NMR spectra were recorded on Bruker AV-400 and 
Bruker DRX-500 spectrometer. Chemical shifts (δ) were expressed 
in ppm with reference to the solvent signals. FAB-MS were 
recorded with a VG Autospec-3000 spectrometer. EI-MS were 
recorded with a VG Autospec-3000 spectrometer. ESI-MS and 
HRESI-MS were recorded with an API QSTAR Pulsar 1 spectro-
meter. Preparative HPLC was performed on an Agilent 1100 series 
with a Zorbax SB-C18 (5 µm, 9.4 × 150 mm) column. Preparative 
MPLC was performed on Büchi apparatus equipped with Büchi 
fraction collector C-660, Büchi pump module C-605 and manager 
C-615. Silica gel (200 to 300 mesh, Qingdao Marine Chemical Inc., 
Qingdao, China), RP-18 gel (40 to 75 µm, Fuji Silysia Chemical Ltd., 
Aichi, Japan) and Sephadex LH-20 (Amersham Biosciences, 
Uppsala, Sweden) were used for column chromatography. 
Fractions were monitored by TLC and spots were visualized under 
visible and UV light (254 and 365 nm). Spots were also visualized 
by heating silica gel plates sprayed with 10% H2SO4 in ethanol. All 
solvents used were of analytical reagent grade. 
 
 
Collection and identification of fungus  
 
Ganoderma species were collected from naturally infected oil palm 
plants of the PAMOL Plantations Ltd, Lobe, South West Region, 
Cameroon   and   were   identified   using   gross   morphology  and  
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microscopy (Ryvarden, 1984). The gross morphology is exemplified 
in Figure 1.   
Basidiospores inclusive ornamentation measured 11 to 14 µm x 8 
to 6 µm, while measurements exclusive of ornamentation were (8) 9 
to 11 (12) x 7 to 5 µm. The microscopic investigation revealed that 
the species    was   G.    zonatum   (Figure 2).   Duplicate    voucher  










specimens (No. HKAS58060 and UB-0083) have been deposited at 
the Herbarium of Kunming Institute of Botany, Chinese Academy of 




Extraction and isolation of secondary metabolites 
 
Fruiting bodies of G. zonatum  (1.4 kg) were oven dried at 70°C for 
48 h. The dried samples were powdered and then extracted three 
times with 8 L of chloroform/methanol in 1:1 ratio (v/v) at room 
temperature. The combined extract was evaporated in a rotator 
evaporator and concentrated in vacuo and the residue was sus-
pended in water and partitioned with petroleum ether, ethylacetate 
and n-hexane. The ethylacetate extract (240 g) was subjected to 
MPLC and then TLC and like fractions were combined to give three 
fractions.  
Fraction 1 (27 g) was chromatographed on silica gel (petroleum 
ether- methanol, 50:1-1:2) to give three sub-fractions 1.1 to 1.3. 
Sub-fraction 1.2 (9 g) was chromatographed on silica gel 
(petroleum ether- acetone, 20:1-1:2) to give compound 1 (15 mg), a 
white powder and compound 4 (90 mg), also a white powder. Sub 
fraction 1.3 (12 g) was subjected to silica gel CC (petroleum ether- 
acetone, 15:1-1:2) to yield compound 6 (21 mg), a white powder, 
while Sub fraction 1.1 was discarded because the quantity was too 
small for purification and analysis. 
Fraction 2 (32 g) was chromatographed on silica gel (petroleum 
ether- methanol, 30:1-1:2) to give four sub-fractions; 2.1 to 2.4. 
Sub-fraction 2.2 (8 g) was chromatographed on silica gel 
(petroleum ether- acetone, 10:1 and 1:2) to yield compound 2 (10.5 
mg).    Sub-fraction    2.3    (10 g)    was    chromatographed    using 
petroleum ether- methanol solvent (30:1 and 1:2) to give compound 
5 (20 mg).  
Fraction 3 (20 g) was subjected to petroleum ether-methanol, 
25:1-1:2 to give three sub-fractions 3.1 to 3.3. Sub fraction 3.1 (5 g) 
was chromatographed on silica gel (petroleum ether- MeOH, 30:1-
1:2) to give four sub-fractions 3.1.1  to 3.1.4. Fraction 3.1.4 (200 
mg) was subjected to silica gel CC (petroleum ether- EtOAc, 12:1-
1:2) to yield six sub-fractions 3.1.4.1 to 3.1.4.6. Sub-fraction 3.1.4.4 
(20 mg) was chromatographed on silica gel (petroleum ether-
acetone, 6:1) to give compound 7 (12 mg). Sub-fraction 3.1.4.6 (10 
mg) was chromatographed on sephadex LH-20 (CHCl3:MeOH 1:1) 
to yield compound 3 (8 mg). Sub-faction 3.1.4.2 was further 





The following human tumour cell lines were used: breast cancer 
MCF-7, hepatocellular carcinoma SMMC7721, human myeloid 
leukaemia HL-60, colonic cancer W480 and lung cancer A549. 
These are cell lines maintained at the Kunming Institute of Botany 
of the Chinese Academy of Sciences, Kunming, China. All cells 
were cultured in RPMI-1640 or DMEM medium (Hyclone, USA), 
supplemented with 10% foetal bovine serum (Hyclone, USA) at 
37°C in a humidified atmosphere with 5% CO2. Cell viability was 
assessed by conducting colorimetric measurements of the amount 
of insoluble formazan formed in living cells based on the reduction 
of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
(MTT), purchased from sigma, USA.
 
Briefly, 100 µl adherent cells 
were seeded into each well of 96-well cell culture plates and 
allowed to adhere for 12 h before  drug  addition,  while  suspended  




cells were seeded just before drug addition, both with initial density 
of 1 × 105 cells/ml in 100 µl medium. Each tumour cell line was 
exposed to the test compound at various concentrations (0.064, 
0.32, 1.6, 8 and 40 µM) in triplicates for 48 h, with cisplatin and 
taxol (sigma, USA) as positive control. After the incubation, MTT 
(100 µg) was added to each well and the incubation continued for 
4 h at 37°C. The cells were lysed with 100 µl 20% SDS-50% DMF 
after removal of 100 µl medium. The optical density of the lysate 
was measured at 595 nm in a 96-well microtitre plate reader (Bio-
Rad 680, USA). The concentration of inhibitors that result in 50% 
inhibition of enzyme activity (IC50) was calculated from the least-
squares regression line of the logarithmic concentrations plotted 





Following purification of the various fractions by 
preparative TLC methods, the spectral analysis revealed 




H NMR and EI Data of 1–8 (in chloroform and 































Colorless amorphorus powder; mp: 182-184oC; El-MS 
m/z(%): 428((M)+,13),410((M-H20)+,5),396((M-02)+, 









Colorless needle; mp: 164-165oC; [α]D 
22 = -103o (c 0.1,CHCl3); UV (CHCl3): λmax nm (log ε) 
274 (4.01), 284 
(4.07), 296 (3.84); EI-MS m/z: 396 [M]+ (76), 271 [M -
C9H17]+ (80), 69 (100).  
 
 
Ergosta-7,22-dien-3β-ol,6 (Stella sterol) 
 
Colorless amorphorus powder; [α]D 22 = -6.8o (c 
0.1,CHCl3); UV (CHCl3): λmax nm (log ε) 239 (3.42); EI-
MS 
m/z: 398 [M]+ (33), 355 [M - (CH3)2CH]+ (8), 271 (100), 








The structures and molecular formulae of the eight pure 
compounds are shown on Table 1.  
Cytotoxic assays against five human cancer cell lines 
with the highly oxygenated lanostane-type triterpenoids 
(lanosta-7,9(11),24-trien-3-one 15,26-dihydroxy, lanosta-
7,9(11),24-trien-26-oic,3-hydroxy and ganoderic acid y) 
revealed that ganoderic acid Y had moderate anticancer 
activity against two human cancer cell lines SMMC-
7721(liver cancer) and A549 (lung cancer) with IC50 
values of 33.5 and 29.9 µM, respectively (Table 2). 
Different concentrations of ganoderic acid Y and their 






Eight pure compounds were isolated for the first time 
from G. zonatum collected from oil palm plantations in 
Cameroon. The eight compounds composed of three 
lanostane-type triterpenoids [lanosta-7,9(11),24-trien-3-
one 15,26-dihydroxy, lanosta-7,9(11),24-trien-26-oic,3-
hydroxy and ganoderic acid y], four steroids [(22E,24R)-
ergosta-7,22-dien-3β,5α.6β-triol, 5α,8α-epidiory 
(22E,24R-ergosta-6,22-dien-3β-ol,Ergosta-5,7,22-trien-
3β-ol,7(ergosterol),  ergosta-7,22-dien-3β-ol,6] and a 
benzene derivative (dimethyl phthalate). This is the first 
report of these compounds from G. zonatum from Came-
roon. Species of the genus Ganoderma are known to be 
prolific producers of lanostane type triterpenoids with 
over 100 compounds having been associated with 
members of the genus (Shim et al., 2004). Although all 
three lanostane-type triterpernoids found in this study 
have   been  reported  separately  from  different  species  




Table 1. Structure, molecular formula and weight of eight secondary metabolites from a Cameroonian oil palm isolate of  
G.zonatum Murill. 
 
Compound Structure, molecular formula and weight 









































C28 H44 O  M=396  


















Table 2. Cytotoxicity of lanosta-7,9(11),24-trien-3-one,15;26-dihydroxy, lanosta-7,9(11),24-trien-26-oic,3-hydroxy 
and ganoderic acid Y to five cancer cell lines. 
 
Test compound 












1 >40 ）40 ）40 ）40 ）40 
113-a
1 ）40 ）40 ）40 ）40 ）40 
113-b
1 ）40 33.51 29.94 ）40 ）40 
Cisplatin (DDP) 0.84 9.86 8.40 18.84 13.51 
TAXOL <0.008 <0.008 <0.008 <0.008 <0.008 
 
*IC50 is the concentration that will allow for only 50% cell viability; 
1
112-b, Lanosta-7,9(11),24-trien-3-one,15;26-





of the fungus, their simultaneous occurrence in G. 
zonatum is reported here for the first time. This 
simultaneous occurrence could be used as a diagnostic 
feature for the species and could serve as a chemo-
taxonomic character. 
The anti-tumour effects of Ganoderma are apparently 
mediated by numerous biologically active compounds 
such as polysaccharides, triterpenes and immuno-
modulatory proteins (Silva et al., 2002). Due to 
differences in climate, composition of extracts and 
culturing methods, individual species of Ganoderma may 
differ in their bioactivity (Chen et al., 2004). 
For the active compound ganoderic acid Y, the 
percentage cell viability of liver and lung cancer cell lines 
was less than 50% at 40 µM concentration, while for HL-
60 (leukaemia), MCF-7 (breast cancer) and SW480 
(colon cancer) it was greater or equal to 50% at the same 
concentration. The reasons for these differences are 
unclear and there is need for further investigation on the 
underlying mechanism of the action of ganoderic acid Y 
on liver and lung cancer cell lines. 
Ganoderic acid Y (113-b), an oxygenated lanostane 
type triterpenoid, has been shown to have biological 
activity. For example, Haijaji et al. (2005) showed that it 
inhibits cholesterol biosynthesis. Also, Berger et al. (2004) 
found that organic fractions of G. lucidum containing 
oxygenated lanosterol derivatives inhibited cholesterol 
synthesis in T9A4 hepatocytes. Toth et al. (1983) also 
isolated ganoderic acid Y from Ganoderma lucidum and 
found that it showed cytotoxic activity in vitro on 
hepatoma cells, while Huie and Di (2004) showed that 
ganoderic acid Y from the fruiting body of G. lucidum 
possess antihypertensive properties and ACE 
(Angiotensin-converting enzymes). In this study, it was 
found to have moderate antiproliferative activity against 
two cancer cell lines; liver and lung cancer cell lines, 
respectively. This affirms the claims of the use of this 
fungus for the treatment of tumours by traditional medical 
practitioners in Cameroon (Yongabi et al., 2004). This 
shows that ganoderic acid Y (113-b) has pharmaceutical 






Based on the literature available to us, this is the first 





bioactivity of compounds from the fruiting bodies of G. 
zonatum. It serves as a baseline study for further 
research on this medicinal mushroom species. The three 
highly oxygenated lanostane triterpenoids isolated from G. 
zonatum, can be used as a taxonomic marker for this 
species since they possess the same molecular weight, 
molecular formula and retention factor value, but with 
slightly different structures. Our recent surveys revealed 
that G. zonatum, a member of the G. lucidum complex, 
was among the most prevalent species on oil palm in 
south western Cameroon. These could serve as a source 
of secondary metabolites. There is need for further 
research in vivo to ascertain the efficacy of ganoderic 
acid Y on lung (A-549) and liver (SMMC-7721) cancer 
cell lines, since they are natural products. There is also 
the need for the research on different species of 
Ganoderma and other macro fungi from Cameroon and 
Africa for their secondary metabolites and subsequently, 
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